Manpreet Bedi, MD

Publications

• Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic Specialties.

  (Beltrán Ponce S, Jagsi R, Florez N, Thomas CR Jr, Banerjee A, Jasti S, Bailey MM, Lawton CAF, Johnstone C, Clarke CN, Bedi M, Jovanovic M, Saeed H.) J Womens Health (Larchmt). 2024 Feb;33(2):218-227 PMID: 38011014 SCOPUS ID: 2-s2.0-85179389889 11/27/2023

• Outcomes and complications of postoperative seroma cavities following soft-tissue sarcoma resection.

  (Andryk LM, Neilson JC, Wooldridge AN, Hackbarth DA, Bedi M, Baynes KE, LoGiudice JA, Slusarczyk SM, King DM.) Front Oncol. 2024;14:1250069 PMID: 38357208 PMCID: PMC10864592 SCOPUS ID: 2-s2.0-85184895863 02/15/2024

• FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.

  (Karmakar D, Lahiri P, Bedi M, Ghosh A, Ghosh A, Barui A, Varshney SK, Lahiri B, Sengupta S.) J Cell Biochem. 2023 Jun;124(6):849-860 PMID: 37158093 05/09/2023

• Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.

  (Wang D, Harris J, Kraybill WG, Eisenberg B, Kirsch DG, Ettinger DS, Kane JM 3rd, Barry PN, Naghavi A, Freeman CR, Chen YL, Hitchcock YJ, Bedi M, Salerno KE, Severin D, Godette KD, Larrier NA, Curran WJ Jr, Torres-Saavedra PA, Lucas DR.) JAMA Oncol. 2023 May 01;9(5):646-655 PMID: 36995690 PMCID: PMC10064284 03/31/2023

• Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.

  (Gutkin PM, Gore E, Charlson J, Neilson JC, Johnstone C, King DM, Hackbarth DA, Wooldridge A, Mannem R, Bedi M.) Radiat Oncol. 2023 Mar 01;18(1):42 PMID: 36859309 PMCID: PMC9976442 SCOPUS ID: 2-s2.0-85149210071 03/02/2023

• Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.

  (Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal H.) J Surg Oncol. 2023 Mar;127(4):550-559 PMID: 36477427 SCOPUS ID: 2-s2.0-85147711222 12/09/2022

• Natural history of intraosseous low-grade chondroid lesions of the proximal humerus.

  (LaPrade CM, Andryk LM, Christensen JL, Neilson JC, Wooldridge AN, Hackbarth DA, Bedi M, King DM.) Front Oncol. 2023;13:1200286 PMID: 37637054 PMCID: PMC10457155 SCOPUS ID: 2-s2.0-85168784928 08/28/2023

• A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer.

  (Small C, Prior P, Nasief H, Zeitlin R, Saeed H, Paulson E, Morrow N, Rownd J, Erickson B, Bedi M.) Brachytherapy. 2023;22(6):728-735 PMID: 37574352 SCOPUS ID: 2-s2.0-85168005570 08/14/2023

• Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies.

  (McAlarnen LA, Small C, Tostrud L, Pan AY, Erickson B, Bedi M, Bradley WH.) Brachytherapy. 2023;22(5):630-639 PMID: 37394350 PMCID: PMC10757857 SCOPUS ID: 2-s2.0-85164349084 07/03/2023

• Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.

  (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA.) Adv Radiat Oncol. 2023;8(4):101206 PMID: 37152489 PMCID: PMC10157111 05/08/2023

• Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database.

  (Gusho CA, King D, Ethun CG, Cardona K, Harrison Howard J, Tran TB, Poultsides G, Tseng J, Roggin KK, Fields RC, Cullinan DR, Chouliaras K, Votanopoulos K, Grignol VP, Bedi M.) J Surg Oncol. 2022 Dec;126(8):1533-1542 PMID: 35962783 SCOPUS ID: 2-s2.0-85135798396 08/14/2022

• Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma.

  (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM.) Adv Radiat Oncol. 2022;7(3):100850 PMID: 35647402 PMCID: PMC9133395 06/02/2022